INTRODUCTION
Infertility affects over 50 million couples, and potentially as many as 186 million people worldwide suffer from fertility issues. Due to limitations regarding precise numbers, the male factor is expected to contribute toward approximately half of all infertility cases. 1 The current diagnostic approaches focus on analysis of standard semen parameters: motility, morphology, and sperm count. Regardless, up to one-third of infertile males are considered as possessing idiopathic sperm abnormalities. 2, 3 However, this issue becomes difficult to address as some sperm donors who do not show abnormalities in semen parameters display issues with conception. It is suggested that, in some cases, molecular defects leading to conception failure may be the root of the problem. Increasing evidence indicates that basic semen analysis does not fully encompass the potential of male fertility. 3, 4 For this reason, plausible sperm biomarkers, such as the expression patterns of sperm RNAs and protein, need to be evaluated instead of reliance on the standard semen parameters. These factors could play a functional role after delivery to the oocyte, or they may play a part in modulation of gene expression processes. The amount of particular RNAs and/or proteins may be a distinguishing factor between fertile and infertile men, even when the latter present normal semen
ORIGINAL ARTICLE
Increased expression of PELP1 in human sperm is correlated with decreased semen quality region of sperm, suggesting their importance in the context of mitochondrial function. 21, 23 Novel findings indicate the primary role of proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) in crosstalk between cellular processes mediated via ESR. Additionally, the mechanistic relationship between G protein-coupled estrogen receptor (GPER30) and the estrogen-related signaling pathway has been reported. 24 Because many environmental factors are described as endocrine estrogen disruptors, which may bind to ESR, GPER30, and the androgen receptor, 25 it is essential to trace the molecular pathway of estrogen action in males. As a result, PELP1 would be placed among the molecules involved in signal modulation of rapid estrogen signaling, particularly in sperm cells.
PELP1 is present both within the cell nucleus and cytoplasm. The genomic action of PELP1 may influence gene expression by binding to H3 and H4 histones and, as a consequence, remodels chromatin structure. Nongenomically, PELP1 is engaged in estrogen-dependent signal transduction based on a social network of phosphorylated protein complexes. [26] [27] [28] It also participates in ribosome biogenesis and serves as a protein-protein mediator in various cellular processes. 29, 30 PELP1 RNA levels and protein expression in mature sperm cells are under scrutiny. 31 Taking into consideration the influence of environmental estrogen-like compounds on the biology of male reproductive system and sperm cells, the aim of our study was to determine a PELP1 expression pattern and compare it with sperm parameters. As postulated, this protein is essential for estradiol-mediated, extranuclear response, and thus plays a crucial role in signal transduction in spermatozoa. We analyzed PELP1 mRNA and protein concentrations in pooled semen samples. First of all, we confirmed its presence in sperm, and then we estimated its cellular localization in the spermatozoa and determined the proportion of PELP1 in subjects presenting normal and abnormal semen parameters.
MATERIALS AND METHODS

Ethical approval statement
The Institutional Review Board at the Poznan University of Medical Sciences, Poznan, Poland, approved this study (No. 553/13). Written informed consent was obtained from each participant. Figure 1 .
Materials
mRNA and protein presence validation
Due to the small amount of RNA in spermatozoa, nine separate trials of pooled semen samples were obtained from 12-18 donors (n = 135). Half of the pooled sample volume was used for RNA extraction and the other half for protein isolation. Swim-up technique was used to obtain a pure fraction of sperm cells from each sample according to the WHO guidelines.
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Analysis of PELP1 mRNA expression Total RNA was isolated using TriPure isolation reagent (Roche, Basel, Switzerland) according to a modified Chomczynski and Sacchi method. 33 The modifications included repeated TriPure isolation step and RNA precipitation at −80°C instead of room temperature (RT) incubation, followed by nucleic acid concentration using a silica matrix column system (ZymoResearch, Irvine, CA, USA). Additionally, the repeated TriPure step during RNA extraction prevented DNA contamination. RNA sample quantity and purity was assessed by measuring absorbance (NanoDrop ND-1000 spectrophotometer; Thermo Fisher Scientific, Waltham, MA, USA) at A260 nm, A230 nm, and A280 nm; and the A230/260 and A260/280 ratios showed that all samples met the criteria for purity (both ratios ranged from 1.9 to 2.0). To evaluate sample integrity, the ribosomal RNA bands were analyzed by 0. Gliwice, Poland) providing denaturing conditions in the presence of ethidium bromide (Sigma-Aldrich).
The reverse transcription reaction was performed according to the Transcriptor reverse transcriptase manufacturer protocol (Roche). The total reaction volume was 10 µl. In the first step, 500 ng of total cellular RNA, DNase, RNase, pyrogen-free water, and 5 pmol µl −1 universal oligo (dT) 10 primer were combined, and the samples were denatured at 65°C for 10 min then cooled on ice. Next, each sample was complemented with 5 pmol µl −1 of each deoxynucleotide triphosphates (dNTPs), 10U for reaction (rxn) ribonuclease inhibitor, 1 × buffer (Transcriptor RT buffer; Roche, Basel, Switzerland), and 10U for rxn of reverse transcriptase. The following thermal profile was applied: 25°C for 10 min, 55°C for 60 min, then 5 min at 85°C. cDNA was immediately used for quantitative polymerase chain reaction (qPCR) or stored at −20°C until further analysis (but no longer than 1 week).
To establish RNA expression, the LightCycler® 2.0 carousel glass capillary-based system was applied (Roche). Primer sequences and TaqMan® hydrolysis probe position for the gene of interest (GOI) were determined using Roche Universal Probe Library Assay Design Center (https://lifescience.roche.com/en_pl/ brands/universal-probe-library.html, last accessed on September 28, 2017). The hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene encoding hypoxanthine-guanine phosphoribosyltransferase was served as an internal control (Roche assay N° 05046157001). The reaction mixture in a total volume of 20 µl contained 5 µl template cDNA (obtained in the reverse transcription reaction step), 1 × LightCycler® FastStart TaqMan® Probe Master (Roche), 0.1 µmol l −1 hydrolysis probe (0.2 µmol l −1 in the case of GOI), and 0.5 µmol l −1 gene-specific primers. The Universal Probe Library (UPL) probe and the sense and antisense primers for the GOI were as follows: probe #62 (Roche cat. N°: 04688619001) and 5'-GCACTGTGTGTCTTGGCTTC-3' and 5'-GAGGAGGTCCCTCAGGACA-3' . The primers were designed so that they annealed in two different exons spaced by a 7.9-kb intron. We used the standard cycling and acquisition reaction profile for UPL probes. 34 Each reaction was performed in duplicate on independently synthetized cDNA. Samples were sequenced to confirm their identity with those deposited in the Nucleotide Database of National Center for Biotechnology Information (GenBank N o : NM_014389.2).
PELP1 protein detection
Sperm cells were suspended in an appropriate volume of isolation buffer (80% phosphate-buffered saline [PBS; PAN-biotech, Aidenbach, Germany]); 10% protein extraction and immunoprecipitation 1 × radio-immunoprecipitation assay (RIPA) buffer (Merck Millipore, Darmstadt, Germany); and 10% protease inhibitor cocktail (Sigma-Aldrich). The samples were incubated for 15 min at 4°C with gentle shaking, then cells were centrifuged (Centrifuge 5812R; Eppendorf, Hamburg, Germany) at 12 000 g, 4°C, l5 min., and the supernatants containing protein extracts were used for western blot analysis. Quick Start Bradford Dye Reagent (BioRad, Hercules, CA, USA) and spectrophotometer (NanoDrop ND-1000; Thermo Fisher Scientific) were used for colorimetrical measurement of extracted proteins (595 nm wavelength) and referred to decimal dilution series of bovine serum albumin fraction V (BSA V; Roche). Thirty micrograms of extracted proteins were separated using 12% SDS-PAGE running buffer (25 1 × TBST). Protein detection was evaluated using primary polyclonal anti-PELP1 rabbit antibody (Bethyl Laboratories, Montgomery, TX, USA) followed by incubation with polyclonal anti-rabbit alkaline phosphatase-conjugated goat secondary antibody (Sigma-Aldrich), both at a 1:2500 dilution (200 rpm orbital shaker, 1 h, 4°C). Each time, unbounded antibodies were rinsed three times in TBST buffer (200 rpm, 10 min, RT). Glyceraldehyde 3-phosphate dehydrogenase protein (GAPDH) extracted from spermatozoa, as well as from the ovarian cancer cell line OVCAR-3 (ATCC, Manassas, VA, USA), was used as internal and external positive control for PELP1 expression. Visualization was performed using the BCIP®/NBT-Blue liquid substrate system for membranes (Sigma-Aldrich). Membranes were digitized using G:BOX Chemi system (Syngene, Cambridge, UK). Western blots were repeated in triplicate for all 9 pooled samples.
Immunocytochemistry
Smears were fixed on glass microscope slides in a 4% buffered paraformaldehyde solution (Avantor Performance Materials Poland S.A.) for 10 min at RT. In order to retrieve antigens, the slides were boiled in a microwave oven twice (2 × 10 min, 200W) in citrate buffer (pH 6.0, 0.1 mol l −1 citric acid solution, 0.1 mol l −1 sodium citrate solution; Avantor Performance Materials Poland S.A.) and then cooled at RT. In order to block endogenous peroxidase activity, slides were incubated for 3 min in 3% hydroxyperoxide solution (Avantor Performance Materials Poland S.A.). To avoid nonspecific antibody binding, the slides were placed in TBST buffer (containing 3% BSA) for 1 h at RT. To evaluate PELP1 protein localization, the same primary antibodies (Bethyl Laboratories) as for western blot were used at a 1:500 dilution. Incubation was carried out overnight at 4°C.
Subsequently, the slides were rinsed three times for 15 min in TBST buffer. In order to identify cellular localization of the antigen, the slides were processed with commercial Dako EnVision + System HRP (DAB) kit (Dako, Glostrup, Denmark) containing a horseradish peroxidase-conjugated anti-rabbit secondary antibody. The detection procedure was provided by the manufacturer. As positive controls, 3 µm dewaxed and rehydrated tissue specimen sections of ovarian cancer were used. Evaluation was performed under the Axiophot light microscope (Zeiss-Opton, Oberkochen, Germany).
Flow cytometry
Cells were separated using a gradient isolation system (Sil-Select Plus, FertiPro N.V., Beernem, Belgium) according to the manufacturer's protocol. Sperm cells from the lower phase were harvested and pelleted (300 g, 10 min, RT), and spermatozoa were fixed in an appropriate volume of 4% buffered paraformaldehyde solution (1 h, RT) followed by centrifugation 10 min, 200 g, 4°C (Centrifuge 5415D, Eppendorf). Next, cells were permeabilized on ice for 20 min in 500 µl 0.1% saponin solution in PBS supplemented with 0.5% BSA. Samples were then centrifuged again under the same conditions, and 100 µl of PELP1 primary polyclonal antibodies were applied at a 1:500 dilution. The incubation period was 1 h on ice. Next, the solution was filled up with saponin (to the maximum volume of the 1.5 ml eppendorf tube), centrifuged (200 g, 5 min, 4°C), and washed with PBS. The next step was a 30-min incubation on ice in darkness with secondary goat anti-rabbit antibody conjugated with fluorescein (Santa Cruz Biotechnology Inc., Dallas, TX, USA) at a 1:100 dilution.
Samples were then filled with saponin solution, centrifuged, and suspended in 500 µl PBS. In the negative control, samples omitted the primary antibody. For each experiment performed using BD FACSCalibur™ flow cytometer (Becton Dickinson Biosciences, San Jose, CA, USA), 10 000 cells were examined. The fluorescence dye was excited by argon laser (488 nm) and emission was measured in the FL1 channel (515-545 nm). All data were gathered and analyzed using BD CellQuest™ Pro software (version 5.2.l; Becton Dickinson). The FACS operator was blinded for the results of the semen analyses. The intensity of fluorescence of PELP1-positive cells derived from patients presenting abnormal semen parameters was compared to the values obtained from patients fulfilling the criteria for normozoospermia.
Statistical analysis
Statistical analysis was performed using Statistica version 12 software for Windows (StatSoft Inc., Tulsa, OK, USA). To describe experimental results, mean ± standard deviation was used. The Shapiro-Wilk test was used for the normality of continuous variables distribution assessment. The Welch's t-test, as well as Mann-Whitney U-test, was applied. The correlation coefficient (r) between sperm parameters and mean fluorescent intensity was determined by the Spearman's rank correlation tests. Using the Medical plugin version 4.0 for Statistica software (StatSoft), the receiver operating characteristic (ROC) curve was created. Subsequently, Hanley and McNeil methods for ROC comparison were used for further analysis of the data and for calculation of the sensitivity and specificity of PELP1 quantification in relation to normal/abnormal semen quality. Data were considered statistically significant at P < 0.05.
RESULTS
PELP1 mRNA and protein validation
PELP1 amplification was confirmed in all analyzed samples using specific primers and TaqMan® probes (Roche, assay N° 05046157001 for HPRT, and probe #62 Roche cat. N°: 04688619001 for PELP1). The reaction product specificity was evaluated by electrophoretic separation in agarose gel, sequencing, and alignment analysis. Based on comparison with the molecular size marker Nova l00 (Novazym, Poznan Poland), bands were observed at a size corresponding to the PELP1 mRNA fragment, in length of 100 bp (Figure 2) . The consensus sequence of the PCR product was confirmed by sequencing analysis and compared to the mRNA of human PELP1, transcript variant 1 (GenBank N o : NM_014389.2).
Western blot analysis confirmed the presence of the PELP1 protein in sperm cells. Immunoreactive bands were observed at approximately 170 kDa, corresponding to the molecular weight of human PELP1. A weak signal was detected in the case of total cellular proteins isolated from swim-up prepared spermatozoa, while a stronger signal was observed in the positive control samples (proteins isolated from ovarian cancer cell line OVCAR-3). The 37 kDa bands of GAPDH reference protein were strongly immunoreactive in all cases (Figure 3) .
Expression pattern analysis
Immunocytochemical staining confirmed the presence of PELP1 protein in human sperm. In cells with normal morphology, strong immunostaining was observed in the midpieces. Likewise, in cells with disturbed morphology (of head, midpiece, and/or tail), PELP1 protein was mostly presented within midpieces. Nuclear PELP1 localization was observed in ovarian cancer tissue samples (positive control) (Figure 4) .
FACS analysis quantified sperm with PELP1 expression. For each sample, 10 000 cells were analyzed. The intensity of fluorescence of PELP1-positive sperm was lower in normozoospermic semen in comparison to abnormal samples (42.78% ± 11.77% vs 61.05% ± 21.70% respectively; P = 0.014; Figure 5 ). In all analyzed parameters, with the exception of viability and total motility, there were differences between mean fluorescence intensity (P ≤ 0.001). The mean expression level was higher in samples with abnormal semen parameters. In the analysis presented in Supplementary Table 2, the parameters described in each row were taken under consideration as the major subgroup determinant (P < 0.01). A negative correlation was found between all sperm parameters and PELP1 expression. The correlation coefficients varied from −0.41 to −0.59 (P < 0.01; Supplementary Table 3 and Figure 6 ). ROC curve analyses for the "normal/abnormal" semen categories revealed areas under the curve (AUC) for PELP1 quantification (0.781; P = 0.0001). The cutoff value of 42.15 made it possible to predict the abnormality in semen quality with a sensitivity of 88% and specificity of 65%.
DISCUSSION
Our analysis of mRNA and protein expression revealed, for the first time, the presence of PELP1 in human spermatozoa using four precise, Until this point, no studies have indicated the presence of PELP1 in spermatozoa. We suspect that PELP1 contributes to the biology of sperm cells. This protein is involved in both genomic and nongenomic pathways of estrogen signal transduction in somatic cells. [35] [36] [37] [38] [39] Besides the presence of RNA, the protein inheritance in mature sperm was confirmed by the western blot analysis. Detection of PELP1 protein can be supported by the presence of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) in the midpiece region of spermatozoa. 40 PI3K is involved in estrogen action, transduced via ESRs. PI3K can influence the regulation of calcium channels through phosphatidylinositol (3,4,5)-trisphosphate and diacylglycerol. Those findings are interesting especially in the context of increased Ca 2+ concentrations observed in the sperm in a quick/nongenomic response to estrogens. 41 The PELP1 expression pattern observed using Axiophot light microscopy indicated its localization in the same region as PI3K in sperm with normal and abnormal parameters (Figure 4) . Considering studies reporting on different cellular localization of PELP1 (cytoplasmic vs nuclear), its function is compartment dependent. 42 Moreover, it has been reported that one ESR isoform can interact with a G-protein-coupled estrogen receptor located in the midpiece. 19, 43, 44 Due to PELP1 interaction with ESR, such localization seems to be justified. The presence of ESRs and PELP1 in the same cellular region could be related to a potential role of estrogens in energy production for motility, capacitation reaction, and sperm fertilizing ability.
In this study, we did not observe significant differences in the PELP1 expression pattern regarding total motility and viability parameters. Surprisingly, in the case of other analyzed parameters, the percentage of PELP1-positive spermatozoa was higher in sperm samples with abnormal parameters. A negative correlation was observed between decreasing PELP1 expression and increasing sperm quality. This may be due to an excess of residual cytoplasm in disturbed sperm morphology or protein redistribution. Moreover, PELP1 was reported to induce nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB) signaling pathway, which is related to inflammatory signals that modulate macrophage activation. 42 Taking all of these into account, this could lead to decrease of sperm parameters.
For the first time, our study demonstrates the presence of PELP1 in spermatozoa and its increased expression in sperm with abnormal parameters.
CONCLUSIONS
This study demonstrates the presence of mRNA, protein, and cellular localization of PELP1 in ejaculated spermatozoa. Flow cytometry analysis showed that the percentage of sperm cells stained with PELP1 antibody is negatively correlated with increasing sperm quality. Thus, it might be a marker of impaired semen quality. To evaluate the exact role of PELP1 in male germ cell development, as well as in mature sperm physiology and pathology, further studies need to be conducted.
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